Oxygenators Market is estimated to be valued at USD 295.2 Mn in 2026 and is expected to reach USD 435.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 295.2 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
5.70% |
2033 Value Projection: |
USD 435.2 Mn |
Oxygenator is used by a perfusionist in cardiac surgery in conjunction with the heart-lung machine. Oxygenators provide gas exchange and may be composed of silicone membrane or hollow fiber. They remove carbon dioxide and adds oxygen to the blood that is pumped into the arterial system. Oxygenators are of two types, such as bubble and membrane oxygenator.
Market Dynamics:
Increase in prevalence of cardiovascular diseases, growing geriatric population, rise in adoption or demand for oxygenators, and availability or introduction of technologically advanced products are major factors expected to drive the growth of the global oxygenators market during the forecast period.
For instance, in January 2021, Eurosets announced the full commercial release (out of USA) of its ECMOlife system for ExtraCorporeal Life Support (ECLS). ECMOlife is a life-saving device and expands Eurosets' portfolio to provide temporary support to patients in different therapeutic areas; ExtraCorporeal Membrane Oxygenation (ECMO) and Mechanical Circulatory Support (MCS).
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global oxygenators market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Owgels Group, Braile Biomedica, Terumo Corporation, Nipro Corporation, Medtronic PLC, Getinge AB, EUROSETS SRL, Chalice Medical Ltd., Gen World Medical Devices, MC3 Cardiopulmonary, LivaNova PLC, MicroPort Scientific Corporation, Senko Medical Instrument Mfg Co. Ltd (MERA), and Xenios AG (Fresenius Medical Company), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global oxygenators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxygenators market.
Detailed Segmentation:
- Global Oxygenators Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Bubble Oxygenator
- Membrane Oxygenator
- Global Oxygenators Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Owgels Group
- Braile Biomedica
- Terumo Corporation
- Nipro Corporation
- Medtronic PLC
- Getinge AB
- EUROSETS SRL
- Chalice Medical Ltd.
- Gen World Medical Devices
- MC3 Cardiopulmonary
- LivaNova PLC
- MicroPort Scientific Corporation
- Senko Medical Instrument Mfg Co. Ltd (MERA)
- Xenios AG (Fresenius Medical Company)